[go: up one dir, main page]

AR002712A1 - PROCESO PARA LA SINTESIS DE UN INHIBIDOR DE PROTEASA DE VIH A PARTIR DE (2S)-4-PICOLIL-2-PIPERAZINA-t-BUTILCARBOXAMIDA Y DICHO COMPUESTO - Google Patents

PROCESO PARA LA SINTESIS DE UN INHIBIDOR DE PROTEASA DE VIH A PARTIR DE (2S)-4-PICOLIL-2-PIPERAZINA-t-BUTILCARBOXAMIDA Y DICHO COMPUESTO

Info

Publication number
AR002712A1
AR002712A1 ARP960101629A AR10162996A AR002712A1 AR 002712 A1 AR002712 A1 AR 002712A1 AR P960101629 A ARP960101629 A AR P960101629A AR 10162996 A AR10162996 A AR 10162996A AR 002712 A1 AR002712 A1 AR 002712A1
Authority
AR
Argentina
Prior art keywords
synthesis
piperazine
protease inhibitor
hiv protease
picolil
Prior art date
Application number
ARP960101629A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AR002712A1 publication Critical patent/AR002712A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Se describe un proceso para síntesis de un inhibidor de proteasa de VIH, clínicamente eficaz, que elimina un paso de su síntesis, mediante una síntesisalternativa convergente usando 2(S)-4-picolil-2-piperazina-t-butilcarboxamida como intermediario. Se describe además dicho procedimiento.
ARP960101629A 1995-03-15 1996-03-05 PROCESO PARA LA SINTESIS DE UN INHIBIDOR DE PROTEASA DE VIH A PARTIR DE (2S)-4-PICOLIL-2-PIPERAZINA-t-BUTILCARBOXAMIDA Y DICHO COMPUESTO AR002712A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/404,798 US5618937A (en) 1995-03-15 1995-03-15 Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide

Publications (1)

Publication Number Publication Date
AR002712A1 true AR002712A1 (es) 1998-04-29

Family

ID=23601087

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101629A AR002712A1 (es) 1995-03-15 1996-03-05 PROCESO PARA LA SINTESIS DE UN INHIBIDOR DE PROTEASA DE VIH A PARTIR DE (2S)-4-PICOLIL-2-PIPERAZINA-t-BUTILCARBOXAMIDA Y DICHO COMPUESTO

Country Status (16)

Country Link
US (1) US5618937A (es)
EP (1) EP0815101B1 (es)
CN (1) CN1100054C (es)
AR (1) AR002712A1 (es)
AT (1) ATE181916T1 (es)
AU (1) AU5173896A (es)
BR (1) BR9607376A (es)
CZ (1) CZ292549B6 (es)
DE (1) DE69603163D1 (es)
EA (1) EA000178B1 (es)
HR (1) HRP960114B1 (es)
SK (1) SK282021B6 (es)
TW (1) TW332205B (es)
UA (1) UA49826C2 (es)
WO (1) WO1996028439A1 (es)
YU (1) YU15496A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700364A (en) * 1995-10-30 1997-12-23 Merck & Co., Inc. Electrochemical oxidation
NL1006305C2 (nl) * 1997-06-13 1998-12-15 Dsm Nv Werkwijze voor de bereiding van (1S,2R)-1-amino-2-indanol-(R,R)-tartraat methanol solvaat.
US7199240B2 (en) * 2002-12-11 2007-04-03 Merck & Co., Inc. Reductive alkylation of saturated cyclic amines
US10620330B2 (en) 2013-03-19 2020-04-14 Westerngeco L.L.C. Estimating translational data
CN110835405B (zh) * 2019-11-28 2020-09-15 安阳师范学院 用于肿瘤检测的高分子生物传感器及制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169952A (en) * 1991-07-02 1992-12-08 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral α-amino epoxides
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
ES2112880T3 (es) * 1991-11-08 1998-04-16 Merck & Co Inc Inhibidores de la proteasa de vih utiles para el tratamiento del sida.
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
US5463067A (en) * 1993-07-16 1995-10-31 Merck & Co., Inc. Process for making HIV protease inhibitors
TW472047B (en) * 1994-02-04 2002-01-11 Merck & Co Inc Process for making HIV protease inhibitors
US5449830A (en) * 1994-03-11 1995-09-12 Marck & Co., Inc. Regiospecific processes to make CIS-1-Amino-2-Alkanol from Diol or Halohydrin
US5420353A (en) * 1994-03-11 1995-05-30 Merck & Co., Inc. Regiospecific process to make cis-1-amino-2-alkanol from epoxide

Also Published As

Publication number Publication date
CZ292549B6 (cs) 2003-10-15
SK122597A3 (en) 1998-02-04
BR9607376A (pt) 1997-12-30
CZ286097A3 (cs) 1998-02-18
EP0815101A1 (en) 1998-01-07
ATE181916T1 (de) 1999-07-15
YU15496A (sh) 1999-03-04
HRP960114A2 (en) 1997-10-31
HRP960114B1 (en) 2000-02-29
WO1996028439A1 (en) 1996-09-19
US5618937A (en) 1997-04-08
EA199700235A1 (ru) 1998-04-30
DE69603163D1 (de) 1999-08-12
AU5173896A (en) 1996-10-02
TW332205B (en) 1998-05-21
CN1183779A (zh) 1998-06-03
CN1100054C (zh) 2003-01-29
EA000178B1 (ru) 1998-12-24
SK282021B6 (sk) 2001-10-08
EP0815101B1 (en) 1999-07-07
UA49826C2 (uk) 2002-10-15

Similar Documents

Publication Publication Date Title
ES2114487B1 (es) Mezcla estabilizante sinergistica.
ES2019899T4 (es) Procedimiento para preparar trans-6-6(2-3(3-o 4-carboxamido-sustituido-pirrol-1-il)-alquil)-4-hidroxipiran-2-onas con actividad inhibidora de la sintesis de colesterol.
DE69507800D1 (de) Verbesserte gewebestützvorrichtungen
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
ES2098921T3 (es) Composiciones de cetoconazol de uso topico.
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
BR0015622A (pt) Processo de limpeza que utiliza ondas ultra-sÈnicas
MX9300550A (es) Estructura de fibra absorbente.
DE69421041D1 (de) Keimhemmungsmittel für kartoffeln
AR006058A1 (es) Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido
GB2331988B (en) Polycyclic sulphamate inhibitors or oestrone sulphatase
GB2331987B (en) Polycyclic sulphamate inhibitors of oestrone sulphatase
EA199800200A1 (ru) Ингибиторы пролилэндопептидазы
AR002712A1 (es) PROCESO PARA LA SINTESIS DE UN INHIBIDOR DE PROTEASA DE VIH A PARTIR DE (2S)-4-PICOLIL-2-PIPERAZINA-t-BUTILCARBOXAMIDA Y DICHO COMPUESTO
ES2177824T3 (es) Procedimiento para la sintesis de arilhidrazina por reduccion de un derivado diazoico.
DK0734392T3 (da) Omdannelse af bisnoralkohol til bisnoraldehyd
BR8405886A (pt) Processo e composicoes referentes a ativacao de agentes branqueadores fluorescentes
ES2186807T3 (es) Inhibidores de trombina.
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
EA199700395A1 (ru) Способ получения ингибиторов протеазы вируса иммунодефицита человека
EA199900740A1 (ru) Способ получения эпросартана (варианты)
ES2128112T3 (es) Nuevas composiciones herbicidas.
AR009995A1 (es) Composicion detergente granulada que comprende la enzima isopeptidasa
BR9606955A (pt) Heterocicloalquenos substituísos
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona